Salla, M.; Guo, J.; Joshi, H.; Gordon, M.; Dooky, H.; Lai, J.; Capicio, S.; Armstrong, H.; Valcheva, R.; Dyck, J.R.B.;
et al. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation. Int. J. Mol. Sci. 2023, 24, 5967.
https://doi.org/10.3390/ijms24065967
AMA Style
Salla M, Guo J, Joshi H, Gordon M, Dooky H, Lai J, Capicio S, Armstrong H, Valcheva R, Dyck JRB,
et al. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation. International Journal of Molecular Sciences. 2023; 24(6):5967.
https://doi.org/10.3390/ijms24065967
Chicago/Turabian Style
Salla, Mohamed, Jimmy Guo, Harshad Joshi, Marilyn Gordon, Hitesh Dooky, Justine Lai, Samantha Capicio, Heather Armstrong, Rosica Valcheva, Jason R. B. Dyck,
and et al. 2023. "Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation" International Journal of Molecular Sciences 24, no. 6: 5967.
https://doi.org/10.3390/ijms24065967
APA Style
Salla, M., Guo, J., Joshi, H., Gordon, M., Dooky, H., Lai, J., Capicio, S., Armstrong, H., Valcheva, R., Dyck, J. R. B., Thiesen, A., Wine, E., Dieleman, L. A., & Baksh, S.
(2023). Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation. International Journal of Molecular Sciences, 24(6), 5967.
https://doi.org/10.3390/ijms24065967